Skip to main content
Kathleen Sakamoto, MD, Pediatric Hematology & Oncology, Palo Alto, CA

KathleenSakamotoMD

Pediatric Hematology & Oncology • Palo Alto, CA

Professor, Pediatrics - Hematology & Oncology, Stanford University Medical Center

Join to view full profile

Dr. Sakamoto is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sakamoto's full profile

Already have an account?

  • Office

    725 Welch Rd
    Palo Alto, CA 94304
    Phone+1 650-497-8000
    Fax+1 310-206-0209

Education & Training

  • Children's Hospital Los Angeles
    Children's Hospital Los AngelesFellowship, Pediatric Hematology/Oncology, 1988 - 1991
  • Children's Hospital Los Angeles
    Children's Hospital Los AngelesResidency, Pediatrics, 1985 - 1988
  • University of Cincinnati College of Medicine
    University of Cincinnati College of MedicineClass of 1985

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1986 - 2025
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2006-2014
  • America's Top Doctors for Cancer Castle Connolly, 2009-2013
  • Top Doctors:Southern California Castle Connolly, 2012
  • Join now to see all

Publications & Presentations

PubMed

Abstracts/Posters

  • Pharmacological Inhibition of Nemo-like Kinase Rescues mTOR-Mediated Translation and Primes Progenitors for Leucine-Stimulated Erythroid Expansion in Pre-Clinical Mode...
    Kathleen M. Sakamoto, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • Pediatric Cancer Research Foundation Announces 2023 Grant Recipients to Accelerate Discovery of New Treatments for Pediatric Cancers
    Pediatric Cancer Research Foundation Announces 2023 Grant Recipients to Accelerate Discovery of New Treatments for Pediatric CancersMay 26th, 2023
  • Cryo-EM Provides New Insights into Acute Myeloid Leukemia
    Cryo-EM Provides New Insights into Acute Myeloid LeukemiaFebruary 14th, 2022
  • Researchers Awarded $31 Million for Clinical Trials to Treat Stroke, Heart Failure, Brain Cancer
    Researchers Awarded $31 Million for Clinical Trials to Treat Stroke, Heart Failure, Brain CancerSeptember 9th, 2021
  • Join now to see all

Grant Support

  • The Role Of CREB In Normal Myelopoiesis And LeukemogenesisNational Heart, Lung, And Blood Institute2012
  • Molecular Pathogenesis Of Diamond Blackfan AnemiaNational Heart, Lung, And Blood Institute2012
  • Career Development And Increasing Diversity In Pediatric Hematology/OncologyNational Cancer Institute2011
  • The Role Of CREB In Normal Myelopoiesis And LeukemogenesisNational Heart, Lung, And Blood Institute2010–2011
  • Molecular Pathogenesis Of Diamond Blackfan AnemiaNational Heart, Lung, And Blood Institute2010–2011
  • Career Development And Increasing Diversity In Pediatric Hematology/OncologyNational Heart, Lung, And Blood Institute2010
  • Training In Developmental HematologyNational Heart, Lung, And Blood Institute2007–2010
  • Molecular And Cellular Characterization Of Myeloproliferative DiseaseNational Heart, Lung, And Blood Institute2007–2010
  • Molecular And Cellular Characterization Of Myeloprolife*National Heart, Lung, And Blood Institute2006–2008
  • The Role Of CREB In LeukemogenesisNational Heart, Lung, And Blood Institute2004–2007
  • Molecular And Cellular Characterization Of MPDNational Heart, Lung, And Blood Institute2005
  • Ubiquitination And Degradation In Cancer TherapyNational Cancer Institute2005
  • Ubiquitination And Degradation In Cancer TherapyNational Cancer Institute2004
  • Molecular Regulation Of Myeliod Cell DifferentiationNational Cancer Institute1996–2000
  • Molecular Characterization Of GM-CSF ActionNational Cancer Institute1993–1997
  • Molecular Regulation Of Myeloid Cell DifferentiationNational Cancer Institute1995
  • Molecular Analysis Of Target Cell Response To Human Gm-CNational Cancer Institute1990–1992
  • Molecular Analysis Of Target Cell Response To Human Gm-CNational Cancer Institute1990

Professional Memberships

Dr. Kathleen Sakamoto, Dr. Kathleen Sakamoto, MD, Dr. K Sakamoto